Anixa Biosciences Inc — Director's Dealing 2012

Sep 10, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2012-09-05

Reporting Person: HERMS HENRY P (Director, Vice President-Finance & CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-09-05	Employee Stock Option	$0.81	D	5000	Acquired	2014-05-10	Common Stock (5000)	Direct
2012-09-05	Employee Stock Option	$1.04	D	70000	Acquired	2014-10-25	Common Stock (70000)	Direct
2012-09-05	Employee Stock Option	$0.83	D	50000	Acquired	2016-05-31	Common Stock (50000)	Direct
2012-09-05	Employee Stock Option	$1.17	D	75000	Acquired	2017-11-11	Common Stock (75000)	Direct
2012-09-05	Employee Stock Option	$0.92	D	100000	Acquired	2019-10-07	Common Stock (100000)	Direct
2012-09-05	Employee Stock Option	$0.145	A	5000	Acquired	2014-05-10	Common Stock (5000)	Direct
2012-09-05	Employee Stock Option	$0.145	A	70000	Acquired	2014-10-25	Common Stock (70000)	Direct
2012-09-05	Employee Stock Option	$0.145	A	50000	Acquired	2016-05-31	Common Stock (50000)	Direct
2012-09-05	Employee Stock Option	$0.145	A	75000	Acquired	2017-11-11	Common Stock (75000)	Direct
2012-09-05	Employee Stock Option	$0.145	A	100000	Acquired	2019-10-07	Common Stock (100000)	Direct

Footnotes

F1: Right-To-Buy, pursuant to the Copytele, Inc. 2003 Share Incentive Plan. The ten transactions involved an amendment of outstanding options resulting in the deemed cancellation of "old" options and the grant of replacement options.